MDA Q2_2019 (Eng ) August 9, 2019 Subject : Interim Management Discussion and Analysis of Q2/2019 Attention : President of The Stock Exchange of Thailand We attach herewith the financial statements
MDA Q2_2018 (Eng.) August 7, 2018 Subject : Interim Management Discussion and Analysis of Q2/2018 Attention : President of The Stock Exchange of Thailand We attach herewith the financial statements
MDA Q3_2018 (Eng.) November 7, 2018 Subject : Interim Management Discussion and Analysis of Q3/2018 Attention : President of The Stock Exchange of Thailand We attach herewith the financial statements
MD&A Q4_2019 (Eng ) February 19, 2020 Subject : Yearly Management Discussion and Analysis of 2019 Attention : President of The Stock Exchange of Thailand We attach herewith the financial statements
Microsoft Word - MD&A Q1_2020 (Eng ) May 8, 2020 Subject : Interim Management Discussion and Analysis of Q1/2020 Attention : President of The Stock Exchange of Thailand We attach herewith the
MD&A Q2_2020 (Eng ) July 31, 2020 Subject : Interim Management Discussion and Analysis of Q2/2020 Attention : President of The Stock Exchange of Thailand We attach herewith the financial statements
Subject Management Discussion and Analysis for the second quarter ended 30 June 2020 Attention President The Stock Exchange of Thailand According to the resolution of the Board of Directors of JAS Asset
MD&A Q3_2020 (Eng ) November 2, 2020 Subject : Interim Management Discussion and Analysis of Q3/2020 Attention : President of The Stock Exchange of Thailand We attach herewith the financial
August 11, 2020 Subject: Management’s Discussion and Analysis for the second Quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries
MDA Q3_2019 (Eng ) November 8, 2019 Subject : Interim Management Discussion and Analysis of Q3/2019 Attention : President of The Stock Exchange of Thailand We attach herewith the financial statements